Substrate behavior can be useful, e.g., in the case of Alzheimer’s disease (AD), where diminished P-gp function has been measured, resulting in increased brain accumulation of a PET tracer and neurotoxic compounds, such as amyloid-β [14]. The gene discussed is PGP; the disease is early-onset autosomal dominant Alzheimer disease.